pyridoxamine has been researched along with pyridoxamine dihydrochloride in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Atkins, RC; Berl, T; Blumenthal, S; Greene, T; Herskovits, T; Hunsicker, LG; Lewis, EJ; Lewis, JB; Packham, DK; Pohl, MA; Raz, I; Reutens, AT; Rohde, RD; Spitalewiz, S; Yagil, Y; Yerushalmy, Y | 1 |
Chen, JL; Francis, J | 1 |
Goldsmith, DJ; Hajhosseiny, R; Jivraj, N; Khavandi, K; Malik, RA; Mashayekhi, S | 1 |
Angelini, ML; Baraldi, O; Cianciolo, G; Iorio, M; Stefoni, S | 1 |
Broome, BR; Dwyer, JP; Fox, JW; Greco, BA; Greene, LE; Lewis, JB; Packham, D; Peterson, R; Sika, M; Umanath, K | 1 |
Gad, SC; Mujer, CV; Peterson, RC; Sullivan, DW | 1 |
Breyer, MD; Susztak, K | 1 |
Begley, P; Chevalier-Riffard, C; Church, SJ; Cooper, GJS; Dowsey, AW; Gardiner, NJ; Grayson, B; Kassab, S; Neill, JC; Phillips, AM; Rotariu, SM; Unwin, RD; Zeef, LAH | 1 |
Biswas, S; Roy, T; Sengupta, P | 1 |
3 review(s) available for pyridoxamine and pyridoxamine dihydrochloride
Article | Year |
---|---|
Have we reached the limits for the treatment of diabetic nephropathy?
Topics: Animals; Diabetic Nephropathies; Humans; Oleanolic Acid; Pyridoxamine; Renin-Angiotensin System; Vitamin D | 2014 |
Emerging drugs for chronic kidney disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Glycosaminoglycans; Humans; Pyridines; Pyridoxamine; Pyrimidines; Pyrrolidines; Renal Insufficiency, Chronic | 2014 |
Developing Treatments for Chronic Kidney Disease in the 21st Century.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Atrasentan; Benzhydryl Compounds; Canagliflozin; Diabetic Nephropathies; Drug Discovery; Endothelin Receptor Antagonists; Glucosides; Glycosaminoglycans; Humans; Hypoglycemic Agents; Mineralocorticoid Receptor Antagonists; Oleanolic Acid; Oxidative Stress; Pyridoxamine; Pyrrolidines; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
3 trial(s) available for pyridoxamine and pyridoxamine dihydrochloride
Article | Year |
---|---|
Pyridorin in type 2 diabetic nephropathy.
Topics: Aged; Creatinine; Cystatin C; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Proteinuria; Pyridoxal Phosphate; Pyridoxamine | 2012 |
Pyridoxamine dihydrochloride in diabetic nephropathy (PIONEER-CSG-17): lessons learned from a pilot study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antioxidants; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Pilot Projects; Pyridoxamine | 2015 |
Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney D
Topics: Acetylcysteine; Adult; Aged; Diet, Protein-Restricted; Dietary Supplements; Disease Progression; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxamine; Renal Insufficiency, Chronic; Taurine | 2022 |
3 other study(ies) available for pyridoxamine and pyridoxamine dihydrochloride
Article | Year |
---|---|
Pyridoxamine, advanced glycation inhibition, and diabetic nephropathy.
Topics: Diabetic Nephropathies; Female; Humans; Male; Pyridoxamine | 2012 |
A 7-day intravenous toxicity study and neurotoxicity assessment of pyridorin in Sprague-Dawley rats.
Topics: Administration, Intravenous; Animals; Female; Male; Neurotoxicity Syndromes; No-Observed-Adverse-Effect Level; Pyridoxal; Pyridoxamine; Pyridoxic Acid; Pyridoxine; Rats, Sprague-Dawley; Toxicity Tests, Subacute; Vitamin B 6 | 2017 |
Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Pyridoxamine; Rats; Rats, Wistar; Recognition, Psychology; Streptozocin | 2019 |